Hormonal replacement therapy and the risk of lung cancer in women: An adaptive meta-analysis of cohort studies

Journal of Preventive Medicine and Public Health

Volumn 48, Issue 6, 2015, Pages 280-286

  Bae, Jong Myon ^a   Kim, Eun Hee ^a  

^a Jeju National University School of Medicine   (South Korea)

Author keywords

Hormone replacement therapy; Lung neoplasms; Meta analysis; Risk factor

Indexed keywords

RECOMBINANT HORMONE;

CANCER HORMONE THERAPY; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EXPOSURE; EFFECT SIZE; FEMALE; HUMAN; LUNG CANCER; MEDLINE; META ANALYSIS; REVIEW; RISK FACTOR; SCOPUS; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); ADVERSE EFFECTS; FACTUAL DATABASE; HORMONE SUBSTITUTION; LUNG NEOPLASMS;

COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LUNG NEOPLASMS; RISK FACTORS;

EID: 84948954596     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.15.054     Document Type: Review

References (41)

1. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47(2):127-141.
2. Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO. Lung cancer incidence by smoking status in Korean men: 16-years of observations in the Seoul Male Cancer Cohort study. J Korean Med Sci 2013;28(4):636-637.
3. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 2011;32(4):605-644.
4. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006;98(10):691-699.
5. Planchard D, Besse B. Lung cancer in never-smokers. Eur Respir J 2015;45(5):1214-1217.
6. Alberg AJ, Wallace K, Silvestri GA, Brock MV. Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol 2013;177(7):613-616.
7. Subramanian J, Govindan R. Lung cancer in 'Never-smokers': a unique entity. Oncology (Williston Park) 2010;24(1):29-35.
8. Krishnan VG, Ebert PJ, Ting JC, Lim E, Wong SS, Teo AS, et al. Whole-genome sequencing of asian lung cancers: secondhand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers. Cancer Res 2014; 74(21):6071-6081.
9. Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: role of estrogens. Expert Rev Respir Med 2010;4(4):509-518.
10. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25(5):561-570.
11. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a diferent disease. Nat Rev Cancer 2007;7(10):778-790.
12. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2(8):506-513.
13. Meireles SI, Esteves GH, Hirata R Jr, Peri S, Devarajan K, Slifker M, et al. Early changes in gene expression induced by tobacco smoke: evidence for the importance of estrogen within lung tissue. Cancer Prev Res (Phila) 2010;3(6):707-717.
14. Oh SW, Myung SK, Park JY, Lym YL, Ju W. Hormone therapy and risk of lung cancer: a meta-analysis. J Womens Health (Larch-mt) 2010;19(2):279-288.
15. Greiser CM, Greiser EM, Dören M. Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-anal-ysis. Maturitas 2010;65(3):198-204.
16. Chen X, Cai L. Meta-analysis of the efects on hormone replacement therapy and oral contraceptives associated with female lung cancer risk. Wei Sheng Yan Jiu 2009;38(6):672-676 (Chinese).
17. Yao Y, Gu X, Zhu J, Yuan D, Song Y. Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis. PLoS One 2013;8(8):e71236.
18. Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, et al. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILC-CO). Br J Cancer 2013;109(7):1954-1964.
19. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44(5):833-839.
20. Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-proges-tin replacement therapy-long-term follow-up of a Swedish cohort. Int J Cancer 1996;67(3):327-332.
21. Bae JM. Narrative reviews. Epidemiol Health 2014;36:e2014018.
22. Bae JM. Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis. Epidemiol Health 2015;37:e2015005.
23. Bae JM. The necessity of an observational study on the interactions between allergic history and citrus fruit intake for the prevention of pancreatic cancer. Epidemiol Health 2015;37: e2015028.
24. Pukkala E, Tulenheimo-Silfvast A, Leminen A. Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997. Cancer Causes Control 2001;12(2):111-115.
25. Olsson H, Bladström A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003;102(3):565-570.
26. Liu Y, Inoue M, Sobue T, Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 2005;117(4):662-666.
27. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 2007;120(10):2214-2220.
28. Corrao G, Zambon A, Conti V, Nicotra F, La Vecchia C, Fornari C, et al. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol 2008; 19(1):150-155.
29. Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ, et al. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2008;17(3):655-660.
30. Smith JR, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Al-Delaimy WK. Hormone use and lung cancer incidence: the Rancho Bernardo cohort study. Menopause 2009;16(5):1044-1048.
31. Slatore CG, Chien JW, Au DH, Satia JA, White E. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol 2010;28(9):1540-1546.
32. Clague J, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV Jr, Henderson KD, et al. Menopausal hormone therapy does not in-fuence lung cancer risk: results from the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2011;20(3):560-564.
33. Brinton LA, Schwartz L, Spitz MR, Park Y, Hollenbeck AR, Gierach GL. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control 2012;23(3):487-496.
34. Brinton LA, Gierach GL, Andaya A, Park Y, Schatzkin A, Hollenbeck AR, et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev 2011;20(5):900-911.
35. Weiss JM, Lacey JV Jr, Shu XO, Ji BT, Hou L, Yang G, et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008; 168(11):1319-1325.
36. Seow A, Koh W P, Wang R, Lee H P, Yu MC. Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2009;18(3):821-827.
37. Baik CS, Strauss GM, Speizer FE, Feskanich D. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 2010;19(10):2525-2533.
38. Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer 2008; 11(1):23-32.
39. Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and pancreatic cancer risk: a quantitative systematic review. Pancreas 2009;38(2): 168-174.
40. Siegfried JM. Smoking out reproductive hormone actions in lung cancer. Mol Cancer Res 2014;12(1):24-31.
41. Koushik A, Spiegelman D, Albanes D, Anderson KE, Bernstein L, van den Brandt PA, et al. Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies. Am J Epidemiol 2012;176(5):373-386.